ENDRA Life Sciences Inc. (NDRA)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$4.61
-4.36%
Mkt Cap $2.57M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 31, 2026 | $100.00K | — | — | -$1.23 | -$3.26 | -165.04% | — | — |
| Q4 2025 Nov 14, 2025 | — | — | — | -$1.95 | -$1.75 | +10.26% | — | — |
| Q3 2025 Aug 14, 2025 | — | — | — | -$2.27 | -$1.71 | +24.67% | — | — |
| Q2 2025 May 15, 2025 | — | — | — | -$3.91 | -$2.59 | +33.76% | — | — |
| Q1 2025 Mar 31, 2025 | — | $211.60K | — | -$4.10 | -$9.40 | -129.27% | — | — |
| Q4 2024 Nov 15, 2024 | — | — | — | -$62.30 | -$5.85 | +90.61% | — | — |
| Q3 2024 Aug 14, 2024 | — | — | — | -$0.07 | -$139.86 | -199700.00% | — | — |
| Q2 2024 May 14, 2024 | — | — | — | -$0.27 | -$454.55 | -168251.85% | — | — |
| Q1 2024 Mar 28, 2024 | — | $428.41K | — | -$0.36 | -$297.20 | -82455.56% | — | — |
| Q4 2023 Nov 14, 2023 | — | — | — | -$0.43 | -$699.30 | -162527.91% | — | — |
| Q3 2023 Aug 14, 2023 | — | — | — | -$0.55 | -$751.75 | -136581.82% | — | — |
| Q2 2023 May 15, 2023 | — | — | — | -$1783.22 | -$1625.87 | +8.82% | — | — |
| Q1 2023 Mar 14, 2023 | $200.00K | — | — | -$1398.60 | -$1818.18 | -30.00% | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | -$2097.90 | -$1748.25 | +16.67% | — | — |
| Q3 2022 Aug 15, 2022 | — | — | — | -$1748.25 | -$2097.90 | -20.00% | — | — |
| Q2 2022 May 12, 2022 | — | — | — | -$2447.55 | -$2447.55 | +0.00% | — | — |
| Q1 2022 Mar 30, 2022 | $225.00K | — | — | -$1.60 | -$2447.55 | -152871.88% | — | — |
| Q4 2021 Nov 15, 2021 | $50.00K | — | — | -$2447.55 | -$2097.90 | +14.29% | — | — |
| Q3 2021 Aug 12, 2021 | — | — | — | -$2447.55 | -$2797.20 | -14.29% | — | — |
| Q2 2021 May 17, 2021 | — | — | — | -$2447.55 | -$2097.90 | +14.29% | — | — |